Trial · NCT02783300
Adverse events5,400
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 5,400
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | Part 1: GSK3326595 12.5 Milligram (mg) Once a Day (QD) | 1 | 1 | 1 |
| other | Fatigue | General disorders | Part 1: GSK3326595 25mg QD | 0 | 1 | 0 |
| other | Fatigue | General disorders | Part 1: GSK3326595 50mg QD | 0 | 1 | 0 |
| other | Fatigue | General disorders | Part 1: GSK3326595 100mg QD | 0 | 1 | 0 |
| other | Fatigue | General disorders | Part 1: GSK3326595 200mg QD | 2 | 8 | 2 |
| other | Fatigue | General disorders | Part 1: GSK3326595 300mg QD | 2 | 3 | 2 |
| other | Fatigue | General disorders | Part 1: GSK3326595 400mg QD | 10 | 19 | 13 |
| other | Fatigue | General disorders | Part 1: GSK3326595 600mg QD | 2 | 3 | 2 |
| other | Fatigue | General disorders | Part 1: GSK3326595 50mg Twice Daily (BID) | 1 | 1 | 2 |
| other | Fatigue | General disorders | Part 1: GSK3326595 100mg BID | 2 | 7 | 2 |
| other | Fatigue | General disorders | Part 1: GSK3326595 150mg BID | 4 | 6 | 4 |
| other | Fatigue | General disorders | Part 1: GSK3326595 200mg BID | 1 | 3 | 1 |
| other | Fatigue | General disorders | Part 1: GSK3326595 300mg QD (Food Effect) | 12 | 15 | 15 |
| other | Fatigue | General disorders | Part 2: GSK3326595 400mg (TNBC) | 7 | 22 | 8 |
| other | Fatigue | General disorders | Part 2: GSK3326595 400mg (mTCC) | 13 | 16 | 18 |
| other | Fatigue | General disorders | Part 2: GSK3326595 400mg (GBM) | 11 | 29 | 19 |
| other | Fatigue | General disorders | Part 2: GSK3326595 400mg (ER+BC) | 18 | 37 | 28 |
| other | Fatigue | General disorders | Part 2: GSK3326595 400mg (HPV+) | 21 | 28 | 22 |
| other | Fatigue | General disorders | Part 2: GSK3326595 400mg (ACC) | 22 | 34 | 27 |
| other | Fatigue | General disorders | Part 2: GSK3326595 300mg (ACC) | 11 | 16 | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02783300/events